Klebsiella pneumoniae is an opportunistic pathogen and a leading cause of hospitalassociated (HA) infections. Patients in intensive care units (ICUs) are particularly at risk, and outbreaks are frequently reported in ICUs. K. pneumoniae is also part of the healthy human microbiome, providing a potential reservoir for HA infection. However, the frequency of K. pneumoniae gut colonization and its contribution to HA infections are not well characterized.
Introduction
Klebsiella pneumoniae is a significant cause of morbidity and mortality worldwide and causes a range of opportunistic infections in susceptible hosts including the young, elderly, immunocompromised, hospitalized and particularly those in intensive care units (ICUs) [1] [2] [3] . Infections with K. pneumoniae are increasingly refractory to antibiotic treatment due to rising rates of antibiotic resistance [4] [5] [6] , and K. pneumoniae is amongst the ESKAPE pathogens responsible for the majority of hospital-associated (HA) infections 7 . The US Centre for Disease Control and Prevention (CDC) have identified carbapenemase-producing (CP) Enterobacteriaceae and extended spectrum beta-lactamase (ESBL) producing Enterobacteriaceae as significant threats to global health, and found Klebsiella species comprised 11% and 23% of healthcareassociated CP and ESBL infections in the US, respectively 4 . The emergence of multidrug resistant (MDR) K. pneumoniae has resulted in a dramatic increase in research into reservoirs and risk factors for HA K. pneumoniae infections, largely focused on ESBL or CP bacteria isolated from infections and intra-hospital outbreaks. These studies have demonstrated transmission of ESBL or CP K. pneumoniae between patients, and show that gastrointestinal (GI) tract colonisation with ESBL or CP K. pneumoniae can be a risk factor for infection 6, 8 . Yet whilst the majority of K. pneumoniae HA infections are not ESBL or CP 3, 9 , there is little data on the frequency and clinical relevance of colonisation with K. pneumoniae more generally.
K. pneumoniae is known to asymptomatically colonise the skin, mouth, respiratory and GI tracts of humans. Analysis of 16S rRNA gene data from healthy volunteers in the human microbiome project detected K. pneumoniae in approximately 10% of samples from the mouth, nares and skin, and 3.8% of stool samples 10 . Two recent studies investigated carriage of K. pneumoniae in the respiratory tracts of healthy individuals in communities in Asia, using bacteriological culture. A 2010 study in Indonesia detected nasopharyngeal carriage in 15% of adults and 7% of children 11 , while a 2014 study in Vietnam detected nasopharyngeal carriage in 2.7% of adults and throat carriage in 14% 12 . In addition, it has recently been shown that patients suffering from CP K. pneumoniae infections (typically clonal group 258), or from pyogenic liver abscess caused by hypervirulent K. pneumoniae (typically clonal group 23), frequently carry their infecting strain in their GI tract for between 30 days (≤74%) and six months (<30%) following discharge from hospital 13 .
If the gut microbiome is a common reservoir for HA K. pneumoniae infection, then the risk of such infections could potentially be mitigated through screening and GI decontamination 14 , as is often done for vancomycin resistant Enterococcus (VRE). The question of whether K. pneumoniae colonisation poses a risk for subsequent infection has been investigated in just two studies to date. A 1971 study found 18.5% of patients admitted to various wards in the Denver Veterans Administration Hospital were positive by culture for rectal carriage of K. pneumoniae, and that carriage was significantly associated with risk of subsequent HA infection (45% vs 11%) 15 . A 2016 study at the University of Michigan Health System tertiary care hospital reported similar colonisation rates (23%) and increased risk of infection following colonisation (5.2% in colonised vs 1.3% in non-colonised) 16 .
In the present study, we assessed the prevalence of K. pneumoniae colonisation in an at-risk cohort in an ICU within a modern, well-equipped, and well-managed tertiary teaching hospital in Australia. Additionally, we investigated whether colonisation on admission enhances risk of subsequent K. pneumoniae infection among ICU patients and the relative contribution of patients' own gut microbiota and intra-hospital transmission to the burden of K. pneumoniae carriage and infection in the ICU.
Methods

Ethics
Ethical approvals for these studies were granted by the Alfred Hospital Ethics Committee (Project numbers #550/12 and #526/13).
Setting and recruitment
The Klebsiella Acquisition Surveillance Project at Alfred Health (KASPAH) was conducted from April 1, 2013 to March 31, 2014. The study included monitoring for all clinical isolates identified as K. pneumoniae infections by the hospital diagnostic laboratory (details in Supplementary Methods) and recruitment of adult patients (≥18 years) in the Alfred Hospital ICU for K. pneumoniae carriage screening via rectal and throat swabs. Verbal consent was needed from patients (or an adult responsible for the patient) for the first nine months (consent-based collection). For the last three months (universal collection) a MDR surveillance study (#526/13) was concurrently conducted in the ICU by our group and did not require verbal consent. Additional details are provided in Supplementary Methods. As no differences were observed in the distributions of age, sex or K. pneumoniae carriage between the patients enrolled during consent-based and universal collection protocols (Supplementary Figure 1) , results from these two groups were combined for all analyses.
Sample and data collection
Baseline screening swabs and accompanying patient data was collected for all study participants as soon as possible after recruitment. Follow-up swabs and data collection were repeated each 5-7 days after baseline for the duration of ICU stay and up to 4 days following transfer to another ward. Details of swabbing procedures, bacterial culture and antimicrobial susceptibility testing are given in Supplementary Methods. Briefly, samples were grown on selective media and any with the appearance of Klebsiella species were investigated using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) and subjected to antimicrobial profiling using Vitek2. Information on age, gender, dates of hospital and ICU admission/s, surgery in the last 30 days, and antibiotic treatment in the last 7 days were extracted from hospital records. Dates of discharge and/or death were extracted from hospital records at the conclusion of the study. All clinical isolates recovered from ICU patients and identified as K. pneumoniae infections by the hospital diagnostic laboratory as part of routine care were included in the study.
Community associated vs healthcare associated carriage
Individuals in the community associated (CA) screening group include patients who were both (i) admitted to the Alfred Hospital ICU either directly (day 0) or via another ward on day 0, 1 or 2 of the original Hospital admission; and (ii) first swabbed on day 0, 1 or 2 of that admission. Patients first swabbed on day 3 or later of their Hospital admission are included in the HA/Day 3+ screening group. Individuals referred to the Alfred Hospital ICU by the trauma ward of another hospital were assumed to be emergency admissions from the community, and were assigned to the CA/Day 0-2 or HA/Day 3+ screening groups according to the day of first swab relative to their Alfred Hospital admission. All other patients transferred from another hospital were included in the HA/D3+ screening group. As such, the CA/Day 0-2 screening groups represent individuals admitted directly to the hospital from the community, whereas the HA/D3+ group includes individuals with recent hospital exposure.
DNA extraction and sequencing
DNA was extracted from overnight cultures using a phenol:chloroform protocol and phase lock gel tubes and sequenced via Illumina HiSeq to generate 125 bp pairedend reads (see Supplementary Methods). Following quality control checks of the sequence data, 148 isolates from 106 patients were subjected to comparative genomic analysis. Data and accession numbers on all isolates included are available in Supplementary Table 1 . A maximum likelihood phylogenetic tree was inferred from an alignment of all SNPs identified within core K. pneumoniae genes using FastTree v2.1.8 17, 18 . Lineages were defined based on this tree using RAMI 19 and multi-locus sequence types were assigned using SRST2 20 . Isolates falling within the same lineage were further investigated to identify pairwise SNPs via assembly and read mapping. Full details of genomic analyses are given in Supplementary Methods.
Statistical analysis
All statistical analyses were conducted using R (v3.3.1), including Fisher's exact test for association and least squares linear regression for modelling the relationship between pairwise genetic distance and time between isolation (details in Supplementary Methods).
Results
K. pneumoniae carriage
A total of 498 ICU patients were recruited and screened for K. pneumoniae carriage. This represents one fifth of all ICU admissions in the study period, and 64% of adults spending more than 72 hours in ICU. Fifty-four patients (10.8%) tested positive at baseline screening (50 GI carriage only, 2 throat carriage only, 2 both). Carriage was detected at the same frequency in males and females (11.0% vs 10.4%; p = 0.9) and there was a trend towards higher carriage rates among older individuals (Supplementary Table 2 ).
We estimated the rate of CA K. pneumoniae GI carriage, among patients recruited and swabbed in the ICU within two days of their first recorded admission to the Hospital (CA/D0-2 group, see Methods), to be 5.9% (95% confidence interval (CI) [3% -8%], Table 1 , Supplementary Table 3 ). The HA GI carriage rate, amongst patients who were first swabbed in the ICU on or after the third day of admission to the Alfred hospital or following referral from another hospital (HA/D3+ group, see Methods), was significantly higher at 19% (95% CI [13.6% -25.7%], OR=3.75, p=0.00001 using Fisher's exact test, Table 1 ).
One third of the participants in the ICU screening study (n=170) contributed one or more follow-up screening swabs ( Table 2 ). The overall GI carriage rate at follow-up was 15.3% (n=26/170), similar to the HA GI carriage rate of 19% (95% CI [0.71 -2.38], OR=1.3, p=0.39). Participants testing positive on follow-up rectal swabs included 19 who tested negative for K. pneumoniae on their baseline rectal swab, yielding a conversion rate of 12%.
None of the 19 CA baseline carriage isolates were MDR ( Table 1) . GI carriage of MDR strains was detected at similar rates among HA baseline isolates (18%, including 4 ESBL and 2 CP isolates, all in patients who had received antibiotics in the last 7 days) and follow-up screening isolates (16% of patients, including 4 with ESBL and 1 with CP isolates). A total of seven patients contributed both baseline and follow-up GI carriage isolates ( Table 2 ). For 4/7 patients the resistance profiles for the follow-up isolate remained the same as the baseline isolate, for 2/7 patients the follow-up isolate was more resistant (one had increased resistance to amoxicillin/clavulanic acid, ticarcillin/clavulanic acid, piperacillin/ tazobactam, ceftazidine and decreased resistance to nitrofurantoin; the other had increased resistance to cefoxitin and nitrofurantoin), and for 1/7 the follow-up isolate was less resistant (decreased resistance to nitrofurantoin).
Klebsiella GI colonisation is a source of infection in ICU
A total of 49 patients (1.8% of all adult ICU admissions) who spent time in the ICU during their hospital stay, were identified as having K. pneumoniae infections (11 ESBL, of which 3 were also CP). Most of these patients (n=39) were in the ICU when the K. pneumoniae-positive diagnostic specimen was taken, and ten were in another ward shortly after transfer from the ICU. Pneumonia was the most frequent form of K. pneumoniae infection in ICU patients (60%), followed by wound infections (15%), non-disseminated UTI (10%) and bacteraemia with sepsis (8%). MDR was most common among wound and blood isolates (>50%) ( Table 3) .
In order to assess whether K. pneumoniae GI carriage on admission to ICU was a risk factor for subsequent K. pneumoniae infection during hospital stay, we examined the subset of 491 individuals whose baseline screening swab was obtained at least two days prior to collection of any clinical specimen from which K. pneumoniae was isolated (Figure 1) . The rate of K. pneumoniae infection was significantly higher amongst patients who were culture-positive for GI carriage at baseline compared to those who were culture-negative (16% vs 3%; OR=6.9, 95% CI [2.3 -19.7], p<0.001, see Figure 1 ). Of all ICU patients who developed K. pneumoniae infections and contributed baseline screening swabs, half (n=13/27, 48%) tested positive for K. pneumoniae GI carriage at baseline (including eight who were screened >2 days prior to developing the infection).
These results show K. pneumoniae GI colonisation was significantly associated with K. pneumoniae infection in ICU patients. To determine whether infections were caused by patients' own colonising bacteria and to identify transmission between ICU patients, we sequenced the genomes of all K. pneumoniae isolated from patients who had spent any time in the ICU during their hospital stay(s). A total of 143 high quality whole genome sequences were obtained from 106 patients, including 56 clinical, 80 GI carriage and 7 throat carriage isolates. Core genome phylogenetic analysis (Figure 2) revealed the presence of 61 lineages of K. pneumoniae sensu stricto (n=111 isolates) and 24 lineages of two closely related species: 20 K. variicola lineages (n=28 isolates) and four K. quasipneumoniae lineages (n=4 isolates). The latter are recently-described species that are closely related to K. pneumoniae and are typically identified as K. pneumoniae using biochemical or proteomics-based methods 21 . The average distance between K. pneumoniae lineages was 0.5% nucleotide divergence, representing thousands of years of evolutionary separation.
Most Klebsiella lineages (n=69/85, 81%) were identified in just one patient, and 60% of patients (n=64) had their own unique lineage not observed in any other patients (Figure 2) . Half of infections (24/49 patients, 49%) were caused by a lineage unique to that patient. Fifteen patients had both GI carriage and infection isolates available for genome comparison, and 12 of these pairs matched at the lineage level (including six patients whose carriage isolate was collected >2 days prior to the infection). Notably, each of these patients carried their own unique K. pneumoniae lineage, except for AH0214 and AH0255 who shared lineage ST323 carriage and infection isolates.
Klebsiella transmission in the ICU
Sixteen Klebsiella lineages were detected in more than one patient (dark shading, Figure 2 ). Lineage sharing between patients could result from recent transmission of bacteria within the hospital (strain sharing), or by independent acquisition of a lineage that has been circulating in the community (lineage sharing). To distinguish these possibilities we compared pairwise SNP distances between isolates from the same patient with those from different patients (Figure 3A) . Intra-patient genetic distances were nearly all (97%) less than 25 SNPs per 5 Mbp and most (82%) were less than 10 SNPs, while between-patient genetic distances ranged from 0 to >5,000 SNPs (Figure 3A) . Using 25 and 10 SNPs per 5 Mbp as cut-offs to indicate likely and very likely strain sharing between patients, we identified five groups of ICU patients that likely shared Klebsiella strains. Strikingly, each of these groups comprised patients with overlapping admissions, making them epidemiologically plausible intrahospital transmission chains (Figure 4) . We identified six patients with infections that were attributable to these intra-hospital transmission chains (n=4 ST681 (K. variicola), n=1 ST323, n=1 ST231; Figure 4) , representing 12% (n=6/49) of all ICU patients with infections. These infections included two episodes of pneumonia, two wound infections and two UTIs, one of which disseminated to cause bacteraemia with sepsis. Of the four donors in the transmission chains, three had pneumonia and one had a wound infection. Most of the infections associated with transmission were MDR (3/4 donors and 3/6 recipients), indicating a strong association between MDR infections and transmission in the ICU (OR 13.6, p=0.002). In addition, we observed four patients whose carriage of K. pneumoniae was attributable to intra-hospital transmission chains but did not result in any recorded K. pneumoniae infection during hospital stay (n=1 ST323 (MDR), n=2 ST215 (non-MDR), n=1 ST15 (MDR)), representing 5% of all patients in whom carriage was detected.
A further 11 lineages were detected in more than one ICU patient each, but were considered unlikely to represent strain sharing due to excessive pairwise SNP distances. The patients carrying these lineages also lacked overlapping ICU admissions (Supplementary Figure 2) . Such lineage sharing could result from independent acquisition in the community prior to hospital admission, but could also potentially be explained by cryptic longer-term transmission chains involving bacteria that persist within the hospital between admissions (for example, in reservoirs such as sinks or drains, or colonisation of healthcare workers [22] [23] [24] ). In the latter case, we would expect the genetic distances between isolates in these clusters to be consistent with the accumulation of genetic variation over time in an evolving reservoir or transmission chain, which could exceed the 25-SNP cut-off if sufficient time has passed between isolations. To assess this, we compared genetic distances with time-between-isolation for pairs of isolates from the same patients and from within the five epidemiologically supported intra-hospital transmission chains (Figure 3B) , which showed a significant log-linear relationship (R 2 =0.25, p=4x10 -8 ) between genetic distance (SNP accumulation) and time. Observed genetic distances for isolate pairs from the 11 multi-patient lineages with non-overlapping stays exceeded the 99% prediction interval of the linear regression model with the exception of two cases that could potentially reflect plausible cryptic transmission chains (Supplementary Figure 2) : (i) patient AH0352's fourth screening swab was positive for ST641 ten months after the isolation of a ST641 isolate from patient KC0038 at a genetic distance of 125 SNPs per 5 Mbp (value within the 95% prediction interval), and (ii) patient AH0620's clinical wound isolate was 83 SNPs per 5 Mbp distant from that isolated from patient AH0416 one month earlier (value exceeds the 95% prediction interval, but falls within the 99% prediction interval).
DISCUSSION
We estimated a 5.9% CA rate for culture-positive GI carriage of K. pneumoniae, similar to the 3.9% estimated amongst healthy individuals in the human microbiome project based on 16S rRNA amplicon sequencing of stool samples 10 . HA carriage amongst ICU patients was estimated to be much higher at 19%, with 12% of patients converting from culture-negative at baseline to culture-positive on follow-up. This likely reflects acquisition of bacteria in the hospital (transmission of strains was directly observed in 5% of cases) and/or selection for growth of pre-existing K. pneumoniae in the GI microbiome during hospitalisation (MDR rate was 18% in HA baseline carriage and 15% at follow-up, but MDR was not detected in CA baseline carriage). The HA rate estimated here is similar to the culture-positive GI carriage rates estimated in other hospital studies 15, 16 . Throat carriage was negligible in our ICU population, much lower than the rates of CA naso/oropharyngeal carriage estimated in both culture-based and culture-free studies 10, 12 . This is possibly due to high rates of intubation in ICU patients, which may substantially alter the local microbial communities.
Our data demonstrate that K. pneumoniae is a common component of the human GI microbiome and of clinical significance in the ICU setting, as: (i) K. pneumoniae carriage on admission to ICU was significantly associated with subsequent K. pneumoniae infection (OR 6.9, p=0.0003), consistent with the results reported from the 1970s Denver study (OR 4.0, p=0.0009 15 ) and the 2016 Michigan study (OR 4.1, p=0.00002 16 ); and (ii) the WGS data confirmed a direct link between colonising and infecting strains in 13 patients (80% of those with paired isolates available for testing), also consistent with the Michigan study 16 . Importantly, we found strong agreement between two methods for estimating the proportion of ICU K. pneumoniae infections that are attributable to infection with patients' own GI microbiota: (i) of all 49 K. pneumoniae infections diagnosed in ICU patients during the study period, 49% were associated with K. pneumoniae lineages unique to the patient; and (ii) of the 27 K. pneumoniae infections diagnosed in ICU patients from whom screening swabs were obtained, 48% occurred in patients who tested positive for prior GI colonisation with K. pneumoniae. In contrast, only 12% of infections showed evidence of resulting from intra-hospital transmission in this setting. This suggests that while measures to reduce cross-contamination between patients are necessary, they are not sufficient to eliminate K. pneumoniae infections in hospitalised patients, and measures to minimise the risk of infection with the patients' own microbiome deserves significant attention [25] [26] [27] .
Key strengths of this study are the prospective cohort design and the use of WGS to confirm species identification and strain relatedness for all K. pneumoniae isolated from ICU patients, regardless of antimicrobial susceptibility. Most previous studies of K. pneumoniae colonisation in hospitals have focused on ESBL and/or CP isolates only, and while infections associated with such strains are most complicated to treat, they do not represent the major burden of K. pneumoniae infections. WGS demonstrated that some isolates identified as K. pneumoniae by MALDI-TOF actually belonged to closely related groups that have recently been described as separate species 21 , K. quasipneumoniae and K. variicola (Figure 2) . Since these species are very closely related to K. pneumoniae sensu stricto (~4% nucleotide divergence), are clinically indistinguishable, and are typically identified as K. pneumoniae in diagnostic laboratories, comparable studies reporting K. pneumoniae carriage encompass the entire K. pneumoniae complex. Hence we included all three species in our summaries of results. WGS also demonstrated that a small number of isolates identified as K. pneumoniae were either not Klebsiella (n=3), were contaminated with a large proportion of DNA from multiple Klebsiella (n=2) or non-Klebsiella (n=3), or had very low Klebsiella mixture (indicated in Figure 2) . These may reflect coinfection followed by selection for different subpopulations in the laboratory used for the different tests, or misidentification by MALDI-TOF. These samples were therefore excluded from high-resolution genomic analysis for attribution purposes (data Figure 1, Supplementary Table 4 ) but were included in calculation of overall rates of infection and carriage, which therefore reflect solely the routine laboratory identification and are directly comparable with other reported results.
The main limitations of the study arise from the swabbing procedure to identify K. pneumoniae colonisation on admission. Efforts were made to collect swabs as soon as possible following admission, however the need to obtain informed consent from the participant or a person responsible and not disrupt patient care meant that it was often not possible to obtain screening swabs on the day of admission. Notably, similar culture-positive rates were observed for swabs collected on day 0, 1 or 2 of admission ( Supplementary Table 3 ), so it is unlikely that this had a significant impact on results. We used rectal swab culture to determine K. pneumoniae GI colonisation status, however while this approach is standard for pathogen carriage screening [28] [29] [30] , its sensitivity to detect K. pneumoniae is not well characterised and likely depends on the K. pneumoniae strain, GI microbiome composition and recent antimicrobial exposures. There is likely a significant false negative rate, particularly for the detection of CA carriage of susceptible organisms in the absence of recent antibiotic treatment. Hence our study probably underestimates the rate of colonisation in the community and the contribution of colonisation to subsequent infection.
Our conclusion that the GI microbiome is a source of K. pneumoniae infections in ICU patients echoes similar findings that colonising strains of S. aureus, A. baumannii, Enterococcus, and Enterobacteriaceae are a common source of HA infections 16, [22] [23] [24] . Routine screening for nasal carriage of methicillin resistant S. aureus (MRSA) or gut carriage of vancomycin resistant Enterococcus (VRE) or ESBL/CP Enterobacteriaceae has been introduced in various hospital settings [28] [29] [30] [31] . A recent study of CP K. pneumoniae in Israel suggested screening and isolation of carriers could help end current outbreaks and prevent future ones 6 . A similar study introduced screening for EBSL K. pneumoniae in order to limit and prevent current and future outbreaks 32 . Whilst those studies focus on screening for CP or ESBL K. pneumoniae, our results indicate that routine screening for general K. pneumoniae carriage in the ICU could also be a valuable tool. In particular, foreknowledge of the antimicrobial susceptibility profiles of K. pneumoniae, as well as other opportunistic pathogens resident in the microbiome, could guide the choice of prophylactic and therapeutic antimicrobial treatment 25, 26, 28 . 
